Literature DB >> 12572539

Fresh from the pipeline. Ezetimibe.

John Earl1, Peter Kirkpatrick.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12572539     DOI: 10.1038/nrd1015

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

1.  Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.

Authors:  Tomás Zambrano; Nicolás Saavedra; Fernando Lanas; José Caamaño; Luis A Salazar
Journal:  Mol Diagn Ther       Date:  2015-02       Impact factor: 4.074

Review 2.  Inhibition of cholesterol absorption: targeting the intestine.

Authors:  Stephen D Lee; Pavel Gershkovich; Jerald W Darlington; Kishor M Wasan
Journal:  Pharm Res       Date:  2012-08-25       Impact factor: 4.200

3.  Identification, synthesis and characterization of process related desfluoro impurity of ezetimibe and HPLC method validations.

Authors:  Esen Bellur Atici; Bekir Karlığa
Journal:  J Pharm Anal       Date:  2015-04-24

4.  Biocatalytic production of bicyclic β-lactams with three contiguous chiral centres using engineered crotonases.

Authors:  Refaat B Hamed; J Ruben Gomez-Castellanos; Luc Henry; Sven Warhaut; Timothy D W Claridge; Christopher J Schofield
Journal:  Commun Chem       Date:  2019-01-24

Review 5.  Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk.

Authors:  Rishi Rikhi; Michael D Shapiro
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.